Ginkgo Bioworks Holdings, Inc.

DNA · NYSE

Ginkgo has moved from broad synthetic-biology promise toward a harder profitability test.

NYSE DNA Stock Research Proof Gate Ginkgo Bioworks Holdings, Inc.Company Deep Dive

Latest ReportJun 5, 2026Ginkgo Bioworks Pivot: Analyzing Synthetic Biology Profitability Shifts Toward Biosecurity Service ContractsView report ->Total Reports1Published reportView all ->Active Discussions0No visible comments yetView discussions ->Member WorkspaceLockedFinancials, timeline, comparisons, scorecard, and discussion require a paid login.View access ->

Member workspace

Financials and workspace tools are for paid members.

Paid login unlocks company financials, filing timeline, peer comparison, scorecard, and discussion. Valuation remains admin-only while we finalize market-data licensing.